Presentation TCT 2016

ACT I Critique: Pro and Con

Presenter: Klaus D. Mathias

October 31, 2016

REGISTER for free or LOG IN to view this content

ACT I Critique: Pro and Con

Structural Heart

Presentation

TCT 2016

Up Next

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Presenter: John G. Webb

October 31, 2016

More slides +

Presentation TCT 2016

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Presenter: John R. Laird Jr.

October 31, 2016

Presentation TCT 2016

Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data

Presenter: Ganesh Manoharan

October 31, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.